Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection
Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designe...
Gespeichert in:
Veröffentlicht in: | Transplant immunology 2009-07, Vol.21 (3), p.140-142 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 142 |
---|---|
container_issue | 3 |
container_start_page | 140 |
container_title | Transplant immunology |
container_volume | 21 |
creator | Sarri, Stephanie Shaw, Steven M Gieschen-Krische, Mary A Archer, Louise Yonan, Nizar Fildes, James E |
description | Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designed to assess HSP60 expression during the rejection process following cardiac transplantation. Methods Intracellular and cell surface endomyocardial concentration of HSP60 was quantified longitudinally in a cohort of heart transplant recipients ( n = 17, 54 biopsy samples) using competitive sandwich ELISA. Results HSP 60 concentration was low before and during an acute rejection episode. Surprisingly an increase of HSP60 was observed in the period following rejection during recovery ( p = 0.026). Conclusions This novel data demonstrates that human endomyocardial HSP60 is increased following an acute rejection episode. This may occur following endomyocardial damage as a result of immune cell infiltration and graft cell damage. However, in contrast to the general assumption that this molecule represents a danger signal, our findings suggest HSP60 expression may be induced as part of a protective response following tissue damage. |
doi_str_mv | 10.1016/j.trim.2009.04.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_864962092</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0966327409000379</els_id><sourcerecordid>67332058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-b3afdf991175717f0a73897224b1b64e4cf9cc8268cf4d51aa7c34fdc9275e943</originalsourceid><addsrcrecordid>eNp9kc2KFDEYRYMoTs_oC7iQrHRVZf4qPyDCMOgojLhQd0JIp77MpKa60iZVar-9KbpBcDGr8MG5l3AuQi8oaSmh8s3QzjnuWkaIaYloCWGP0IZqpZtOGPYYbYiRsuFMiTN0XspAKtEZ9RSdUcO1ZJpu0I_Ph-Rd7qMb8R24GZe75O_xPqcZ4oQlwfBnn6GUmCYcC17qcbuMboYehzSO6XecbrHzywz42ONxhgH8XAPP0JPgxgLPT-8F-v7h_berj83Nl-tPV5c3jReCzs2Wu9AHYyhVnaIqEKe4NooxsaVbKUD4YLzXTGofRN9R55TnIvTeMNWBEfwCvT721m__XKDMdheLh3F0E6SlWC2FkYwYVslXD5JScc5IpyvIjqDPqZQMwe6ra5cPlhK72reDXe3b1b4lwla3NfTy1L5sd9D_i5x0V-DtEYBq41eEbIuPMHnoY67KbJ_iw_3v_ov7MU7Ru_EeDlCGtOSperbUFmaJ_bruv85PTJ2eK8P_Atr2q70</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67332058</pqid></control><display><type>article</type><title>Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Sarri, Stephanie ; Shaw, Steven M ; Gieschen-Krische, Mary A ; Archer, Louise ; Yonan, Nizar ; Fildes, James E</creator><creatorcontrib>Sarri, Stephanie ; Shaw, Steven M ; Gieschen-Krische, Mary A ; Archer, Louise ; Yonan, Nizar ; Fildes, James E</creatorcontrib><description>Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designed to assess HSP60 expression during the rejection process following cardiac transplantation. Methods Intracellular and cell surface endomyocardial concentration of HSP60 was quantified longitudinally in a cohort of heart transplant recipients ( n = 17, 54 biopsy samples) using competitive sandwich ELISA. Results HSP 60 concentration was low before and during an acute rejection episode. Surprisingly an increase of HSP60 was observed in the period following rejection during recovery ( p = 0.026). Conclusions This novel data demonstrates that human endomyocardial HSP60 is increased following an acute rejection episode. This may occur following endomyocardial damage as a result of immune cell infiltration and graft cell damage. However, in contrast to the general assumption that this molecule represents a danger signal, our findings suggest HSP60 expression may be induced as part of a protective response following tissue damage.</description><identifier>ISSN: 0966-3274</identifier><identifier>EISSN: 1878-5492</identifier><identifier>DOI: 10.1016/j.trim.2009.04.002</identifier><identifier>PMID: 19386281</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acute cardiac rejection ; Allergy and Immunology ; Chaperonin 60 - biosynthesis ; Female ; Graft Rejection - drug therapy ; Graft Rejection - immunology ; Heart Transplantation - immunology ; Heat shock protein 60 ; Humans ; Immune system ; Immunosuppressive Agents - therapeutic use ; Male ; Middle Aged ; Myocardium - immunology ; Up-Regulation</subject><ispartof>Transplant immunology, 2009-07, Vol.21 (3), p.140-142</ispartof><rights>Elsevier B.V.</rights><rights>2009 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-b3afdf991175717f0a73897224b1b64e4cf9cc8268cf4d51aa7c34fdc9275e943</citedby><cites>FETCH-LOGICAL-c441t-b3afdf991175717f0a73897224b1b64e4cf9cc8268cf4d51aa7c34fdc9275e943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.trim.2009.04.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19386281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sarri, Stephanie</creatorcontrib><creatorcontrib>Shaw, Steven M</creatorcontrib><creatorcontrib>Gieschen-Krische, Mary A</creatorcontrib><creatorcontrib>Archer, Louise</creatorcontrib><creatorcontrib>Yonan, Nizar</creatorcontrib><creatorcontrib>Fildes, James E</creatorcontrib><title>Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection</title><title>Transplant immunology</title><addtitle>Transpl Immunol</addtitle><description>Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designed to assess HSP60 expression during the rejection process following cardiac transplantation. Methods Intracellular and cell surface endomyocardial concentration of HSP60 was quantified longitudinally in a cohort of heart transplant recipients ( n = 17, 54 biopsy samples) using competitive sandwich ELISA. Results HSP 60 concentration was low before and during an acute rejection episode. Surprisingly an increase of HSP60 was observed in the period following rejection during recovery ( p = 0.026). Conclusions This novel data demonstrates that human endomyocardial HSP60 is increased following an acute rejection episode. This may occur following endomyocardial damage as a result of immune cell infiltration and graft cell damage. However, in contrast to the general assumption that this molecule represents a danger signal, our findings suggest HSP60 expression may be induced as part of a protective response following tissue damage.</description><subject>Acute cardiac rejection</subject><subject>Allergy and Immunology</subject><subject>Chaperonin 60 - biosynthesis</subject><subject>Female</subject><subject>Graft Rejection - drug therapy</subject><subject>Graft Rejection - immunology</subject><subject>Heart Transplantation - immunology</subject><subject>Heat shock protein 60</subject><subject>Humans</subject><subject>Immune system</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardium - immunology</subject><subject>Up-Regulation</subject><issn>0966-3274</issn><issn>1878-5492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEYRYMoTs_oC7iQrHRVZf4qPyDCMOgojLhQd0JIp77MpKa60iZVar-9KbpBcDGr8MG5l3AuQi8oaSmh8s3QzjnuWkaIaYloCWGP0IZqpZtOGPYYbYiRsuFMiTN0XspAKtEZ9RSdUcO1ZJpu0I_Ph-Rd7qMb8R24GZe75O_xPqcZ4oQlwfBnn6GUmCYcC17qcbuMboYehzSO6XecbrHzywz42ONxhgH8XAPP0JPgxgLPT-8F-v7h_berj83Nl-tPV5c3jReCzs2Wu9AHYyhVnaIqEKe4NooxsaVbKUD4YLzXTGofRN9R55TnIvTeMNWBEfwCvT721m__XKDMdheLh3F0E6SlWC2FkYwYVslXD5JScc5IpyvIjqDPqZQMwe6ra5cPlhK72reDXe3b1b4lwla3NfTy1L5sd9D_i5x0V-DtEYBq41eEbIuPMHnoY67KbJ_iw_3v_ov7MU7Ru_EeDlCGtOSperbUFmaJ_bruv85PTJ2eK8P_Atr2q70</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Sarri, Stephanie</creator><creator>Shaw, Steven M</creator><creator>Gieschen-Krische, Mary A</creator><creator>Archer, Louise</creator><creator>Yonan, Nizar</creator><creator>Fildes, James E</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20090701</creationdate><title>Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection</title><author>Sarri, Stephanie ; Shaw, Steven M ; Gieschen-Krische, Mary A ; Archer, Louise ; Yonan, Nizar ; Fildes, James E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-b3afdf991175717f0a73897224b1b64e4cf9cc8268cf4d51aa7c34fdc9275e943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acute cardiac rejection</topic><topic>Allergy and Immunology</topic><topic>Chaperonin 60 - biosynthesis</topic><topic>Female</topic><topic>Graft Rejection - drug therapy</topic><topic>Graft Rejection - immunology</topic><topic>Heart Transplantation - immunology</topic><topic>Heat shock protein 60</topic><topic>Humans</topic><topic>Immune system</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardium - immunology</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sarri, Stephanie</creatorcontrib><creatorcontrib>Shaw, Steven M</creatorcontrib><creatorcontrib>Gieschen-Krische, Mary A</creatorcontrib><creatorcontrib>Archer, Louise</creatorcontrib><creatorcontrib>Yonan, Nizar</creatorcontrib><creatorcontrib>Fildes, James E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Transplant immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sarri, Stephanie</au><au>Shaw, Steven M</au><au>Gieschen-Krische, Mary A</au><au>Archer, Louise</au><au>Yonan, Nizar</au><au>Fildes, James E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection</atitle><jtitle>Transplant immunology</jtitle><addtitle>Transpl Immunol</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>21</volume><issue>3</issue><spage>140</spage><epage>142</epage><pages>140-142</pages><issn>0966-3274</issn><eissn>1878-5492</eissn><abstract>Abstract Background Heat shock proteins (HSPs) are endogenous adjuvants which are upregulated following cellular injury. HSP60 may be upregulated in response to myocardial injury, inducing activation via TLR ligation on monocytes, dendritic cells and T cells. On these grounds, this study was designed to assess HSP60 expression during the rejection process following cardiac transplantation. Methods Intracellular and cell surface endomyocardial concentration of HSP60 was quantified longitudinally in a cohort of heart transplant recipients ( n = 17, 54 biopsy samples) using competitive sandwich ELISA. Results HSP 60 concentration was low before and during an acute rejection episode. Surprisingly an increase of HSP60 was observed in the period following rejection during recovery ( p = 0.026). Conclusions This novel data demonstrates that human endomyocardial HSP60 is increased following an acute rejection episode. This may occur following endomyocardial damage as a result of immune cell infiltration and graft cell damage. However, in contrast to the general assumption that this molecule represents a danger signal, our findings suggest HSP60 expression may be induced as part of a protective response following tissue damage.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>19386281</pmid><doi>10.1016/j.trim.2009.04.002</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0966-3274 |
ispartof | Transplant immunology, 2009-07, Vol.21 (3), p.140-142 |
issn | 0966-3274 1878-5492 |
language | eng |
recordid | cdi_proquest_miscellaneous_864962092 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Acute cardiac rejection Allergy and Immunology Chaperonin 60 - biosynthesis Female Graft Rejection - drug therapy Graft Rejection - immunology Heart Transplantation - immunology Heat shock protein 60 Humans Immune system Immunosuppressive Agents - therapeutic use Male Middle Aged Myocardium - immunology Up-Regulation |
title | Myocardial heat shock protein 60 expression is upregulated following acute cardiac rejection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A49%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myocardial%20heat%20shock%20protein%2060%20expression%20is%20upregulated%20following%20acute%20cardiac%20rejection&rft.jtitle=Transplant%20immunology&rft.au=Sarri,%20Stephanie&rft.date=2009-07-01&rft.volume=21&rft.issue=3&rft.spage=140&rft.epage=142&rft.pages=140-142&rft.issn=0966-3274&rft.eissn=1878-5492&rft_id=info:doi/10.1016/j.trim.2009.04.002&rft_dat=%3Cproquest_cross%3E67332058%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67332058&rft_id=info:pmid/19386281&rft_els_id=1_s2_0_S0966327409000379&rfr_iscdi=true |